Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 2 |
AABA
Altaba Inc
AABA
|
+$1.44B |
| 3 |
AGN
Allergan plc
AGN
|
+$547M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$525M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$510M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$688M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$427M |
| 3 |
Blackstone
BX
|
+$416M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$391M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.44% |
| 2 | Financials | 10.55% |
| 3 | Healthcare | 8.78% |
| 4 | Consumer Discretionary | 7.66% |
| 5 | Industrials | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AL
2126
DELISTED
Air Lease Corp
AL
| $13.3M | ﹤0.01% |
318,791
-117,413
| -27% | -$4.83M |
|
|
RARX
2127
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $13.3M | ﹤0.01% |
563,719
+348,385
| +162% | +$10.3M |
|
|
AMED
2128
DELISTED
Amedisys
AMED
| $13.3M | ﹤0.01% |
101,633
+15,468
| +18% | +$2.01M |
|
2129
PUT
McCormick & Company Non-Voting
MKC
$13.7B
| $13.3M | ﹤0.01% |
170,000
| – | – |
|
2130
Bruker
BRKR
$9.57B
| $13.2M | ﹤0.01% |
301,306
-103,548
| -26% | -$4.64M |
|
2131
Ericsson
ERIC
$32.2B
| $13.2M | ﹤0.01% |
1,650,015
+131,216
| +9% | +$1.12M |
|
2132
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $13.1M | ﹤0.01% |
518,757
+367,421
| +243% | +$9.23M |
|
|
BBBY
2133
DELISTED
Bed Bath & Beyond Inc
BBBY
| $13.1M | ﹤0.01% |
1,231,948
-1,263,081
| -51% | -$12.2M |
|
2134
PUT
Lockheed Martin
LMT
$134B
| $13.1M | ﹤0.01% |
33,600
-20,300
| -38% | -$7.63M |
|
|
BOLD
2135
DELISTED
Audentes Therapeutics, Inc
BOLD
| $13M | ﹤0.01% |
463,852
+126,156
| +37% | +$4.31M |
|
2136
Churchill Downs
CHDN
$5.88B
| $13M | ﹤0.01% |
210,730
+32,978
| +19% | +$1.99M |
|
2137
Vanda Pharmaceuticals
VNDA
$307M
| $13M | ﹤0.01% |
979,117
+325,430
| +50% | +$4.54M |
|
2138
PUT
Burlington
BURL
$23.2B
| $13M | ﹤0.01% |
+65,000
| New | +$12M |
|
2139
InterContinental Hotels
IHG
$23.9B
| $13M | ﹤0.01% |
207,958
+12,922
| +7% | +$844K |
|
2140
CALL
Phillips 66
PSX
$84.9B
| $12.9M | ﹤0.01% |
126,200
-60,000
| -32% | -$6.01M |
|
2141
PUT
Altria Group
MO
$114B
| $12.9M | ﹤0.01% |
315,900
-161,300
| -34% | -$7.42M |
|
2142
Fabrinet
FN
$15.6B
| $12.9M | ﹤0.01% |
247,013
-56,615
| -19% | -$2.97M |
|
2143
Ares Capital
ARCC
$13.5B
| $12.9M | ﹤0.01% |
692,384
-191,683
| -22% | -$3.55M |
|
2144
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $12.9M | ﹤0.01% |
121,070
-169
| -0.1% | -$18K |
|
|
BHVN
2145
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.9M | ﹤0.01% |
308,534
+69,567
| +29% | +$2.94M |
|
|
IMMU
2146
DELISTED
Immunomedics Inc
IMMU
| $12.8M | ﹤0.01% |
967,068
-109,966
| -10% | -$1.62M |
|
2147
Central Garden & Pet Co Class A
CENTA
$2.37B
| $12.8M | ﹤0.01% |
576,026
+105,980
| +23% | +$2.11M |
|
2148
Heron Therapeutics
HRTX
$93.9M
| $12.8M | ﹤0.01% |
690,041
-62,370
| -8% | -$1.15M |
|
2149
Gold Fields
GFI
$29B
| $12.8M | ﹤0.01% |
2,594,573
+798,696
| +44% | +$4.35M |
|
2150
Helen of Troy
HELE
$644M
| $12.7M | ﹤0.01% |
80,652
-37,869
| -32% | -$5.63M |
|
Similar funds
Goldman Sachs's Q3 2019 Portfolio in Review
As of Q3 2019, Goldman Sachs held 5,584 positions worth $346B, down 0.39% from $347B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs's Q3 2019 filing shows 478 new, 2,283 increased, 2,044 reduced and 441 closed positions. Its largest new stake was ProSight Global, Inc.: 17,005,092 shares worth $329M. The largest sale was Anadarko Petroleum, an estimated $688M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q3 2019 buy was ProSight Global, Inc.: 17,005,092 shares worth $329M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.87B increase.
- Goldman Sachs's biggest Q3 2019 reduction was Blackstone, cutting an estimated $416M.
- Goldman Sachs fully exited Anadarko Petroleum in Q3 2019, selling an estimated $688M.
- Goldman Sachs's ten largest holdings make up 14% of its $346B portfolio in Q3 2019.
- Goldman Sachs opened 478 new positions and closed 441 in Q3 2019.
- Goldman Sachs's portfolio value fell 0.39% quarter-over-quarter to $346B.
Based on Goldman Sachs's 13F filing for Q3 2019, filed 14 Nov 2019.